Breast Cancer Genes and Contralateral Prophylactic Mastectomy: Beyond BRCA
- PMID: 37633854
- DOI: 10.1245/s10434-023-14161-4
Breast Cancer Genes and Contralateral Prophylactic Mastectomy: Beyond BRCA
References
-
- Giannakeas V, Lim DW, Narod SA. The risk of contralateral breast cancer: a SEER-based analysis. Br J Cancer. 2021;125(4):601–10. https://doi.org/10.1038/s41416-021-01417-7 . (Epub 2021 May 26 PMID: 34040177). - DOI - PubMed - PMC
-
- Metcalfe K, Lynch HT, Ghadirian P, Tung N, Olivotto I, Warner E, Olopade OI, Eisen A, Weber B, McLennan J, Sun P, Foulkes WD, Narod SA. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol. 2004;22(12):2328–35. https://doi.org/10.1200/JCO.2004.04.033 . (PMID: 15197194). - DOI - PubMed
-
- Zhang JQ, Dos Anjos CH, Sevilimedu V, Crown A, Amoroso KA, Pilewski ML, Robson ME, Gemignani ML, Association of moderate-risk breast cancer genes with contralateral prophylactic mastectomy and bilateral disease. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-14141-8 . - DOI - PubMed
-
- Yao K, Stewart AK, Winchester DJ, Winchester DP. Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998–2007. Ann Surg Oncol. 2010;17(10):2554–62. https://doi.org/10.1245/s10434-010-1091-3 . (Epub 2010 May 12 PMID: 20461470). - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
